Skip to content
value.today

Paragon Bioservices, Inc.

🇺🇸 Baltimore, Maryland, USABiotechnologyFounded 2014
Total raised
$23 M
4 rounds on record
Latest round
$5 M
Aug 2018
First round on record
Oct 2014
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Paragon Bioservices, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2018$5 MNo. 4$2 to $10 million

Paragon Bioservices, Inc.: Raise no. 4, Aug 2018

Investors in this round

9 investors had bought by the notice of Aug 6, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$10,408
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter Buzy · Executive Officer, Director
  • Donald Hughes · Director
  • Kapila Ratnam · Director
  • Marco Chacon · Director
  • Patrick Hervy · Director
  • Robert Roche · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Buzy, CEO & President. Source: SEC Form D, newest notice filed Aug 6, 2018. Read the notice at the SEC.

equitySEC
May 2017$2 MNo. 3$2 to $10 million

Paragon Bioservices, Inc.: Raise no. 3, May 2017

Investors in this round

9 investors had bought by the notice of May 26, 2017: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$20,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Convertible promissory note convertible into shares of preferred stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Peter Buzy · Executive Officer, Director
  • Donald Hughes · Director
  • Kapila Ratnam · Director
  • Marco Chacon · Director
  • Patrick Hervy · Director
  • Robert Roche · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Peter Buzy, CEO & President. Source: SEC Form D, newest notice filed May 26, 2017. Read the notice at the SEC.

debt, optionsSEC
Aug 2015$2 MNo. 2$2 to $10 million

Paragon Bioservices, Inc.: Raise no. 2, Aug 2015

Investors in this round

7 investors had bought by the notice of Aug 18, 2015: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Shares of Series A-1 Preferred Stock and Warrants to acquire shares of Series A-1 Preferred stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Marco Chacon · Executive Officer, Director
  • Peter Buzy · Executive Officer
  • Christopher Kersey · Director
  • Kapila Ratnam · Director
  • Patrick Hervy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Marco Chacon, Ceo. Source: SEC Form D, newest notice filed Aug 18, 2015. Read the notice at the SEC.

equity, optionsSEC
Oct 2014$14 MNo. 1$10 to $50 million

Paragon Bioservices, Inc.: Raise no. 1, Oct 2014

Investors in this round

7 investors had bought by the notice of Nov 4, 2014: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$624,399
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Marco Chacon · Executive Officer, Director
  • Peter Buzy · Executive Officer
  • Christopher Kersey · Director
  • Kapila Ratnam · Director
  • Patrick Hervy · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • 1st Bridgehouse Securities, LLC (CRD 44655) · Columbia, MarylandSold in MD, PA

Remarks in the notice

  • On fees: “Advisory fee paid to 1st Bridgehouse Securities, LLC included $624,399.52 in cash and warrants to acquire 360,000 shares of the Issuer's Series A Preferred Stock at an exercise price of $1.10 per share.”

Signed by Marco Chacon, President and CEO. Source: SEC Form D, newest notice filed Nov 4, 2014. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Paragon Bioservices, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2018).

    SEC Form D · Aug 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Aug 2018

That is all the official record says: Paragon Bioservices, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Paragon Bioservices, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Paragon Bioservices, Inc.
NameRoleNamed in
Peter BuzyExecutive officerAug 2018
Marco ChaconExecutive officerAug 2015
Donald HughesDirectorAug 2018
Kapila RatnamDirectorAug 2018
Marco ChaconDirectorAug 2018
Patrick HervyDirectorAug 2018
Peter BuzyDirectorAug 2018
Robert RocheDirectorAug 2018
Christopher KerseyDirectorAug 2015